Dhanuka Agritech Limited has informed the Exchange regarding Change in Auditors of the company.
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhanuka Agritech's Board approved audited financial results for Q4 and FY25. Standalone revenue from operations rose to Rs. 2,03,515 lacs in FY25 from Rs. 1,75,854 lacs in FY24, a ~16% jump, with Q4 revenue at Rs. 44,202 lacs vs Rs. 36,831 lacs a year ago. Profit after tax for FY25 stood at Rs. 23,909 lacs with basic EPS of Rs. 65.55 (vs Rs. 52.46), while Q4 PAT was Rs. 7,550 lacs. The Board recommended a 100% final dividend of Rs. 2 per share with July 18, 2025 as the record date. The 40th AGM is scheduled for August 1, 2025. Independent Director Mr. Siraz Azmat Chaudhary will cease on completion of his first term from July 22, 2025. The Board also appointed M/s. Ranjeet Pandey & Associates as Secretarial Auditors for five years and re-appointed M/s. N. Khandelwal & Co. as Cost Auditors for FY26. Notably, during the year the company completed a Rs. 100 crore buyback and acquired international rights from Bayer AG for two active ingredients (Iprovalicarb and Triadimenol), planning expansion into 20+ countries.
Positive: strong revenue and EPS growth alongside a full dividend payout and a meaningful international expansion move via the Bayer deal are shareholder-friendly. The independent director's exit is routine end-of-term and unlikely to affect operations.